Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Cost of Revenue: 2021-2025

Historic Cost of Revenue for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $77.2 million.

  • Core Scientific's Cost of Revenue fell 19.17% to $77.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $312.3 million, marking a year-over-year decrease of 22.33%. This contributed to the annual value of $389.6 million for FY2024, which is 2.81% up from last year.
  • Per Core Scientific's latest filing, its Cost of Revenue stood at $77.2 million for Q3 2025, which was up 4.88% from $73.6 million recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's Cost of Revenue peaked at $189.6 million during Q3 2022, and registered a low of $39.7 million during Q1 2021.
  • In the last 3 years, Core Scientific's Cost of Revenue had a median value of $90.2 million in 2024 and averaged $90.1 million.
  • In the last 5 years, Core Scientific's Cost of Revenue surged by 246.61% in 2022 and then tumbled by 48.60% in 2023.
  • Over the past 5 years, Core Scientific's Cost of Revenue (Quarterly) stood at $160.4 million in 2021, then grew by 5.03% to $168.5 million in 2022, then plummeted by 39.09% to $102.6 million in 2023, then decreased by 12.15% to $90.2 million in 2024, then declined by 19.17% to $77.2 million in 2025.
  • Its Cost of Revenue was $77.2 million in Q3 2025, compared to $73.6 million in Q2 2025 and $71.3 million in Q1 2025.